Charles A. Sanders

CHARLES A. SANDERS, Member of the President's Committee of Advisers on Science and Technology "THE SCIENTIST is unique in that it keeps you abreast of the happenings and personalities in science. The articles are clear and easily understood by readers who may not be well versed in science." Charles Sanders's 40-year career in science has run the gamut in the public and private sectors. A cardiologist by practice, he has been a physician, teacher, and hospital administrator, formerly serving a

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

"THE SCIENTIST is unique in that it keeps you abreast of the happenings and personalities in science. The articles are clear and easily understood by readers who may not be well versed in science."

Charles Sanders's 40-year career in science has run the gamut in the public and private sectors. A cardiologist by practice, he has been a physician, teacher, and hospital administrator, formerly serving as a professor of medicine at Harvard Medical School and general director of the Massachusetts General Hospital, Boston. He has also been a leader in the pharmaceutical industry, having been vice chairman of the Squibb Corp., Princeton, N.J., and chairman and CEO of Glaxo Inc., Durham, N.C.

Sanders has first-hand knowledge of the heavy commitment of the pharmaceutical industry to biomedical research. He says: "The academic establishment has been the steam engine of basic research. And private industry has been the major force for developing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies